Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry

References

• Taubenberger JK, Kash JC. Influenza Virus Evolution, Host Adaptation, and Pandemic Formation. Cell Host & Microbe. 2010;7(6):440-51. doi:10.1016/j.chom.2010.05.009
   PubMed Web of Science ®Google Scholar
• Nelson MI, Holmes EC. The evolution of epidemic influenza. Nat Rev Genet. 2007;8(3):196-205. doi:10.1038/nrg2053. PMID:17262054
   PubMed Web of Science ®Google Scholar
• Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull. 1979;35(1):69-75. doi:10.1093/oxfordjournals.bmb.a071545. PMID:367490
   PubMed Web of Science ®Google Scholar
• Mancini N, Solforosi L, Clementi N, De Marco D, Clementi M, Burioni R. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza. Antiviral Res. 2011;92(1):15-26. doi:10.1016/j.antiviral.2011.07.013. PMID:21798290
   PubMed Web of Science ®Google Scholar
• Stohr K, Bucher D, Colgate T, Wood J. Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol Biol. 2012;865:147-62. doi:10.1007/978-1-61779-621-0_9. PMID:22528158
   PubMedGoogle Scholar
• Johansson BE, Bucher DJ, Kilbourne ED. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol. 1989;63(3):1239-46. PMID:2915381
   PubMed Web of Science ®Google Scholar
• Johansson BE, Moran TM, Bona CA, Popple SW, Kilbourne ED. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J Immunol. 1987;139(6):2010-4. PMID:3624874
   PubMed Web of Science ®Google Scholar
• Virk RK, Gunalan V, Tambyah PA. Influenza infection in human host: Challenges in making a better influenza vaccine. Expert Rev Anti Infect Ther. 2016;14(4):365-75. doi:10.1586/14787210.2016.1155450. PMID:26885890
   PubMed Web of Science ®Google Scholar
• Sriwilaijaroen N, Suzuki Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226-49. doi:10.2183/pjab.88.226. PMID:22728439
   PubMed Web of Science ®Google Scholar
• Wang CC, Chen JR, Tseng YC, Hsu CH, Hung YF, Chen SW, Chen CM, Khoo KH, Cheng TJ, Cheng YS, et al. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci U S A. 2009;106(43):18137-42. doi:10.1073/pnas.0909696106. PMID:19822741
   PubMed Web of Science ®Google Scholar
• Wanzeck K, Boyd KL, McCullers JA. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med. 2011;183(6):767-73. doi:10.1164/rccm.201007-1184OC. PMID:20935106
   PubMed Web of Science ®Google Scholar
• Chen W, Zhong Y, Qin Y, Sun S, Li Z. The Evolutionary Pattern of Glycosylation Sites in Influenza Virus (H5N1) Hemagglutinin and Neuraminidase. PLoS ONE. 2012;7(11):e49224. doi:10.1371/journal.pone.0049224. PMID:23133677
   PubMed Web of Science ®Google Scholar
• Kim JI, Park MS. N-linked glycosylation in the hemagglutinin of influenza A viruses. Yonsei Med J. 2012;53(5):886-93. doi:10.3349/ymj.2012.53.5.886. PMID:22869469
   PubMed Web of Science ®Google Scholar
• Sun X, Jayaraman A, Maniprasad P, Raman R, Houser KV, Pappas C, Zeng H, Sasisekharan R, Katz JM, Tumpey TM. N-Linked Glycosylation of the Hemagglutinin Protein Influences Virulence and Antigenicity of the 1918 Pandemic and Seasonal H1N1 Influenza A Viruses. J Virol. 2013;87(15):8756-66. doi:10.1128/JVI.00593-13. PMID:23740978
   PubMed Web of Science ®Google Scholar
• de Vries RP, de Vries E, Bosch BJ, de Groot RJ, Rottier PJ, de Haan CA. The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology. 2010;403(1):17-25. doi:10.1016/j.virol.2010.03.047. PMID:20441997
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen S, Yang D, Wang X, Zhu J, Peng D, Liu X. Role of stem glycans attached to haemagglutinin in the biological characteristics of H5N1 avian influenza virus. J Gen Virol. 2015;96(Pt 6):1248-57. doi:10.1099/vir.0.000082. PMID:25667326
   PubMed Web of Science ®Google Scholar
• Roberts PC, Garten W, Klenk HD. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virol. 1993;67(6):3048-60. PMID:8497042
   PubMed Web of Science ®Google Scholar
• Herve PL, Lorin V, Jouvion G, Da Costa B, Escriou N. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity. Virology. 2015;486:134-45. doi:10.1016/j.virol.2015.08.033. PMID:26433051
   PubMed Web of Science ®Google Scholar
• Medina RA, Stertz S, Manicassamy B, Zimmermann P, Sun X, Albrecht RA, Uusi-Kerttula H, Zagordi O, Belshe RB, Frey SE, et al. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci Transl Med. 2013;5(187):187ra70. doi:10.1126/scitranslmed.3005996. PMID:23720581
   PubMed Web of Science ®Google Scholar
• Sun S, Wang Q, Zhao F, Chen W, Li Z. Glycosylation Site Alteration in the Evolution of Influenza A (H1N1) Viruses. PLoS ONE. 2011;6(7):e22844. doi:10.1371/journal.pone.0022844. PMID:21829533
   PubMed Web of Science ®Google Scholar
• Tate MD, Job ER, Deng YM, Gunalan V, Maurer-Stroh S, Reading PC. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses. 2014;6(3):1294-316. doi:10.3390/v6031294. PMID:24638204
   PubMed Web of Science ®Google Scholar
• Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA. Structural basis of pre-existing immunity to the 2009 H1N1 pandemic influenza virus. Science (New York, NY). 2010;328(5976):357-60. doi:10.1126/science.1186430
   Google Scholar
• Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A. Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin. PLoS ONE. 2010;5(1):e8553. doi:10.1371/journal.pone.0008553. PMID:20049332
   PubMed Web of Science ®Google Scholar
• NetNGlyc. NetNGlyc 1.0 Server Available: http://www.cbs.dtu.dk/services/NetNGlyc/. Accessed 22 may, 2016.
   Google Scholar
• Doll S, Burlingame AL. Mass spectrometry-based detection and assignment of protein posttranslational modifications. ACS Chem Biol. 2015;10(1):63-71. doi:10.1021/cb500904b. PMID:25541750
   PubMed Web of Science ®Google Scholar
• Thaysen-Andersen M, Packer NH. Advances in LC–MS/MS-based glycoproteomics: Getting closer to system-wide site-specific mapping of the N- and O-glycoproteome. Biochim Biophys Acta, Proteins Proteomics. 2014;1844(9):1437-52. doi:10.1016/j.bbapap.2014.05.002
   PubMed Web of Science ®Google Scholar
• Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbò P, Ince WL, Bennink JR, Yewdell JW. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc Natl Acad Sci U S A. 2011;108(51):E1417-E22. doi:10.1073/pnas.1108754108. PMID:22106257
   PubMed Web of Science ®Google Scholar
• Das SR, Puigbo P, Hensley SE, Hurt DE, Bennink JR, Yewdell JW. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog. 2010;6(11):e1001211. doi:10.1371/journal.ppat.1001211
   PubMed Web of Science ®Google Scholar
• Thaysen-Andersen M, Packer NH. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology. 2012;22(11):1440-52. doi:10.1093/glycob/cws110. PMID:22798492
   PubMed Web of Science ®Google Scholar
• An Y, Rininger JA, Jarvis DL, Jing X, Ye Z, Aumiller JJ, Eichelberger M, Cipollo JF. Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms. J Proteome Res. 2013;12(8):3707-20. doi:10.1021/pr400329k. PMID:23848607
   PubMed Web of Science ®Google Scholar
• Wei C-J, Boyington JC, Dai K, Houser KV, Pearce MB, Kong W-P, Yang Z-y, Tumpey TM, Nabel GJ. Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design. Sci Transl Med. 2010;2(24):24ra1-ra1. doi:10.1126/scitranslmed.3000799
   Web of Science ®Google Scholar
• Ohuchi M, Ohuchi R, Feldmann A, Klenk HD. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol. 1997;71(11):8377-84. PMID:9343193
   PubMed Web of Science ®Google Scholar
• Schauer R. Sialic acids as antigenic determinants of complex carbohydrates. Adv Exp Med Biol. 1988;228:47-72. doi:10.1007/978-1-4613-1663-3_2. PMID:2459931
   PubMedGoogle Scholar
• Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol. 2009;19(5):507-14. doi:10.1016/j.sbi.2009.06.003. PMID:19699080
   PubMed Web of Science ®Google Scholar
• Shi X, Jarvis DL. Protein N-Glycosylation in the Baculovirus-Insect Cell System. Curr drug targets. 2007;8(10):1116-25. doi:10.2174/138945007782151360. PMID:17979671
   PubMed Web of Science ®Google Scholar
• Mir-Shekari SY, Ashford DA, Harvey DJ, Dwek RA, Schulze IT. The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study. J Biol Chem. 1997;272(7):4027-36. doi:10.1074/jbc.272.7.4027. PMID:9020110
   PubMed Web of Science ®Google Scholar
• Fukuda M, Guan JL, Rose JK. A membrane-anchored form but not the secretory form of human chorionic gonadotropin-alpha chain acquires polylactosaminoglycan. J Biol Chem. 1988;263(11):5314-8. PMID:2451668
   PubMed Web of Science ®Google Scholar
• Soema PC, Kompier R, Amorij J-P, Kersten GFA. Current and next generation influenza vaccines: Formulation and production strategies. Eur J Phar Biopharm. 2015;94:251-63. doi:10.1016/j.ejpb.2015.05.023
   PubMed Web of Science ®Google Scholar
• Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E. Flucelvax (Optaflu) for seasonal influenza. Expert Rev Vaccines. 2015;14(6):789-804. doi:10.1586/14760584.2015.1039520. PMID:25968069
   PubMed Web of Science ®Google Scholar
• Yang LP. Recombinant trivalent influenza vaccine (flublok((R))): A review of its use in the prevention of seasonal influenza in adults. Drugs. 2013;73(12):1357-66. doi:10.1007/s40265-013-0103-6. PMID:23928902
   PubMed Web of Science ®Google Scholar
• Zhang S. Comparative Characterization of the Glycosylation Profiles of an Influenza Hemagglutinin Produced in Plant and Insect Hosts. Proteomics. 2012;12(8):1269-88. doi:10.1002/pmic.201100474. PMID:22577028
   PubMed Web of Science ®Google Scholar
• Butler M, Spearman M. The choice of mammalian cell host and possibilities for glycosylation engineering. Curr Opin Biotechnol. 2014;30:107-12. doi:10.1016/j.copbio.2014.06.010. PMID:25005678
   PubMed Web of Science ®Google Scholar
• Squires RB, Noronha J, Hunt V, García-Sastre A, Macken C, Baumgarth N, Suarez D, Pickett BE, Zhang Y, Larsen CN, et al. Influenza Research Database: An integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses. 2012;6(6):404-16. doi:10.1111/j.1750-2659.2011.00331.x. PMID:22260278
   PubMed Web of Science ®Google Scholar